Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up

NCT03090503 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Psychotic Disorders
Psychosis

Interventions

DRUG: Aripiprazole
DRUG: Risperidone

Sponsor

Fundación Marques de Valdecilla

Collaborators

[object Object]
[object Object]